Stephens downgraded Accolade (ACCD) to Equal Weight from Overweight with a price target of $7.03, down from $8, after the company released its fiscal Q3 results this morning via 10-Q with no call, as expected, following the announcement earlier this week of a definitive agreement for Transcarent to purchase Accolade for $7.03 per share. The firm is downgrading shares given that they are trading within 3% of deal price and it expects the deal to close without issue at the announced price, the analyst tells investors.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACCD:
- Options Volatility and Implied Earnings Moves Today, January 09, 2025
- Accolade downgraded to Market Perform from Outperform at Raymond James
- Accolade downgraded to Hold from Buy at Stifel
- Accolade downgraded to Hold from Buy at Needham
- Exxon and Shell cautious on Q4, Flutter cuts guidance: Morning Buzz